Çavuşoğlu Cengiz, Edeer Karaca Neslihan, Azarsız Elif, Ulusoy Ezgi, Kütükçüler Necil
Ege University Faculty of Medicine, Department of Medical Microbiology, Izmir, Turkey.
Mikrobiyol Bul. 2015 Apr;49(2):272-7. doi: 10.5578/mb.8779.
It is well known that disseminated Mycobacterium bovis BCG infection is developed after BCG vaccination in infants with congenital cellular immune deficiencies such as mutations in genes along the interleukin (IL)-12/interferon (IFN)-γ pathway and mutations in nuclear factor-kB essential modulator (NEMO). In this report, a rifampicin-resistant M.bovis BCG strain isolated from an infant with NEMO defect was presented. An 8-month-old male infant with NEMO defect admitted to the pediatric outpatient clinic of our hospital with fever, generalized lymphadenopathy and hepatosplenomegaly. Microscopic examination of the smears prepared from lymph node and liver biopsy specimens revealed abundant amount (3+) of acid-fast bacilli (AFB). Rifampicin-susceptible Mycobacterium tuberculosis complex (MTC) was detected by real-time PCR (GeneXpert MTB/RIF; Cepheid, USA) in the samples. The growth of mycobacteria was determined on the 20th day of culture performed in MGIT960 system (Becton Dickinson, USA). The isolate was identified as M.bovis BCG by GenoType MTBC kit (Hain Lifescience, Germany) and defined as M.bovis BCG [SIT 482 (BOV_1)] by spoligotyping. In the primary anti-tuberculosis drug susceptibility test performed by MGIT960 system, the isolate was found susceptible to rifampicin (RIF), isoniazid (INH), streptomycin (STM) and ethambutol (EMB). Then anti-tuberculosis treatment was started to the patient. However, the patient at the age of 2 years, re-admitted to the hospital with the complaint of hepatosplenomegaly. Smear of spontaneously draining abscess material obtained from subcutaneous nodules revealed intensive AFB positivity (3+) once again. In the present instance RIF-resistant MTC was detected with GeneXpert system in the specimen. The growth of mycobacteria was determined on the 13th day of culture and isolate was identified as M.bovis BCG. The present isolate was found susceptible to INH, STM and EMB but resistant to RIF. A mutation in the rpoB gene (codon 531, S531L) associated with RIF resistance was detected by using the partial sequencing of the rpoB gene. Patient died due to disseminated bovis BCG infection and multiple organ failure. To our knowledge, there are only six RIF-resistant M.bovis BCG strains isolated from patients in the literature. However, this is the first RIF-resistant M.bovis BCG strain isolated from a NEMO-deficient patient.
众所周知,在患有先天性细胞免疫缺陷的婴儿中,如白细胞介素(IL)-12/干扰素(IFN)-γ途径相关基因突变以及核因子-κB必需调节因子(NEMO)基因突变,卡介苗接种后会发生播散性牛分枝杆菌卡介苗感染。在本报告中,呈现了一株从患有NEMO缺陷的婴儿分离出的耐利福平牛分枝杆菌卡介苗菌株。一名患有NEMO缺陷的8个月大男婴因发热、全身淋巴结肿大和肝脾肿大入住我院儿科门诊。对淋巴结和肝活检标本制备的涂片进行显微镜检查发现大量(3+)抗酸杆菌(AFB)。通过实时PCR(GeneXpert MTB/RIF;美国 Cepheid公司)在样本中检测到对利福平敏感的结核分枝杆菌复合群(MTC)。在MGIT960系统(美国BD公司)中培养20天后确定分枝杆菌的生长情况。通过GenoType MTBC试剂盒(德国Hain Lifescience公司)将分离株鉴定为牛分枝杆菌卡介苗,并通过间隔寡核苷酸分型将其定义为牛分枝杆菌卡介苗[SIT 482(BOV_1)]。在MGIT960系统进行的初次抗结核药物敏感性试验中,发现该分离株对利福平(RIF)、异烟肼(INH)、链霉素(STM)和乙胺丁醇(EMB)敏感。随后对该患者开始抗结核治疗。然而,该患者在2岁时因肝脾肿大再次入院。从皮下结节获取的自发引流脓肿材料涂片再次显示抗酸杆菌强阳性(3+)。在本次病例中,通过GeneXpert系统在标本中检测到耐利福平的MTC。培养13天后确定分枝杆菌的生长情况,分离株被鉴定为牛分枝杆菌卡介苗。发现本次分离株对INH、STM和EMB敏感,但对RIF耐药。通过对rpoB基因进行部分测序检测到与利福平耐药相关的rpoB基因突变(密码子531,S531L)。患者因播散性牛分枝杆菌卡介苗感染和多器官衰竭死亡。据我们所知,文献中仅报道了6株从患者中分离出的耐利福平牛分枝杆菌卡介苗菌株。然而,这是首次从NEMO缺陷患者中分离出耐利福平牛分枝杆菌卡介苗菌株。